Previous studies have demonstrated significantly elevated expression of CENPL in liver, breast, and pancreatic cancer samples compared to normal samples, suggesting that high expression of CENPL may serve as a potential prognostic indicator for patients with liver, breast, and pancreatic cancers [47–50]. Here, CENPL is linked to pancreatic neoplasm.